Analysis and Summary of China's Imports and Exports of Vaccines (HS: 30024100) in the Year 2023
“According to customs data, in 2023, the total import volume of Chinese vaccines for human use (HS: 30024100) was 1,758,333 kilograms, representing a year-on-year increase of 35.19%.”
A vaccine is a preventive medical measure that activates the immune system by introducing a pathogen or its components, such as proteins, viruses, or bacteria. This enables the body to mount a faster and more effective immune response when confronted with the actual pathogen. The primary purpose of vaccines is to activate the body's immune system without causing illness, inducing the production of antibodies or cellular immune responses to enhance resistance against specific pathogens.
With the increasing awareness of health protection and ongoing scientific advancements, the innate immune potential of the human body is continuously being explored. The concept of 'vaccines' is not only applied to disease prevention but has also become an indispensable part of the treatment and prevention processes for infectious diseases. This has led to a growing demand for vaccines as people's awareness of health protection rises, consequently driving the continuous expansion of the vaccine market. Chinese vaccines play a crucial role globally, holding significant importance in meeting the demands of both domestic and international markets for vaccines. This is particularly significant in addressing global outbreaks, highlighting the essential role of Chinese vaccines in such situations.
According to customs data, in 2023, the total import volume of Chinese vaccines for human use (HS: 30024100) was 1,758,333 kilograms, representing a year-on-year increase of 35.19%. The total export volume was 161,868 kilograms, showing a year-on-year decrease of 80.5%. In contrast, the export volume in 2021 reached a historic high, totaling 15,635,885,005 kilograms, with a staggering year-on-year growth of 2954.42%. The significant fluctuations in these figures are closely tied to the global pandemic. Of the total export volume in 2023, 510,178 kilograms were attributed to medical aid and donations, accounting for 10.2% of the overall export volume.
According to customs data, in 2023, China's major export destinations for vaccines for human use included Pakistan, India, Thailand, Venezuela, Myanmar, Ethiopia, Indonesia, Egypt, Brazil, and Nicaragua.
In the 2021 export data, the primary markets for China were the United Arab Emirates, Bangladesh, Pakistan, Morocco, Indonesia, and Argentina. The year-on-year growth rates for these markets in the same period were 11.06%, 576.77%, 584.81%, 8002.53%, 22.12%, and 956.11%, respectively.
Medical aid accounted for 3.84% of the overall vaccine export market to Bangladesh, 13.24% to Pakistan, and 1.75% to Indonesia. (Note: Human vaccines were coded as HS: 30022000 before 2022.)
At a global level, medical aid plays a crucial role in addressing public health challenges, particularly in the face of sudden events such as pandemics and natural disasters. International collaboration is essential during these times, and concerted efforts are required from the global community. China actively provided medical assistance during the pandemic, demonstrating a sense of international responsibility and solidarity. This effort has gained widespread recognition globally. Such international cooperation holds positive significance for effectively controlling and ultimately overcoming the pandemic.
It is important to note that the vaccine market is dynamic, and the global demand for and acceptance of COVID-19 vaccines are constantly evolving. Therefore, when seeking the latest market information regarding Chinese vaccines internationally, it is advisable to refer to the most recent news reports and relevant data.
Guomao Tong, as China's first data company, offers comprehensive customs data for over 80 countries from 2010 to the present. We specialize in providing accurate online analyses of import and export market distributions, detailed transaction information for enterprises, specific quantity and price analyses, supply cycles, and more. Our services aim to furnish reliable data for major foreign trade enterprises and industry consulting firms, serving as a dependable basis for decision-making.
(This article is an original creation by Guomao Tong. Please indicate the source when reposting.)
